Natural Killer Cell Therapeutics and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Natural Killer (NK) Cell Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Natural Killer (NK) Cell Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Natural Killer (NK) Cell Therapeutics Overall Market Size
2.1 Global Natural Killer (NK) Cell Therapeutics Market Size: 2022 VS 2035
2.2 Global Natural Killer (NK) Cell Therapeutics Market Size, Prospects & Forecasts: 2018-2035
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Natural Killer (NK) Cell Therapeutics Players in Global Market
3.2 Top Global Natural Killer (NK) Cell Therapeutics Companies Ranked by Revenue
3.3 Global Natural Killer (NK) Cell Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Natural Killer (NK) Cell Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Natural Killer (NK) Cell Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Natural Killer (NK) Cell Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Natural Killer (NK) Cell Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Natural Killer (NK) Cell Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Natural Killer (NK) Cell Therapeutics Market Size Markets, 2022 & 2035
4.1.2 Mogamulizumab
4.1.3 Lorvotuzumab Mertansine
4.1.4 Others
4.2 By Type - Global Natural Killer (NK) Cell Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Natural Killer (NK) Cell Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Natural Killer (NK) Cell Therapeutics Revenue, 2024-2035
4.2.3 By Type - Global Natural Killer (NK) Cell Therapeutics Revenue Market Share, 2018-2035
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Natural Killer (NK) Cell Therapeutics Market Size, 2022 & 2035
5.1.2 Cancer
5.1.3 Cardiovascular Diseases
5.1.4 Others
5.2 By Application - Global Natural Killer (NK) Cell Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Natural Killer (NK) Cell Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global Natural Killer (NK) Cell Therapeutics Revenue, 2024-2035
5.2.3 By Application - Global Natural Killer (NK) Cell Therapeutics Revenue Market Share, 2018-2035
6 Sights by Region
6.1 By Region - Global Natural Killer (NK) Cell Therapeutics Market Size, 2022 & 2035
6.2 By Region - Global Natural Killer (NK) Cell Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Natural Killer (NK) Cell Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Natural Killer (NK) Cell Therapeutics Revenue, 2024-2035
6.2.3 By Region - Global Natural Killer (NK) Cell Therapeutics Revenue Market Share, 2018-2035
6.3 North America
6.3.1 By Country - North America Natural Killer (NK) Cell Therapeutics Revenue, 2018-2035
6.3.2 US Natural Killer (NK) Cell Therapeutics Market Size, 2018-2035
6.3.3 Canada Natural Killer (NK) Cell Therapeutics Market Size, 2018-2035
6.3.4 Mexico Natural Killer (NK) Cell Therapeutics Market Size, 2018-2035
6.4 Europe
6.4.1 By Country - Europe Natural Killer (NK) Cell Therapeutics Revenue, 2018-2035
6.4.2 Germany Natural Killer (NK) Cell Therapeutics Market Size, 2018-2035
6.4.3 France Natural Killer (NK) Cell Therapeutics Market Size, 2018-2035
6.4.4 U.K. Natural Killer (NK) Cell Therapeutics Market Size, 2018-2035
6.4.5 Italy Natural Killer (NK) Cell Therapeutics Market Size, 2018-2035
6.4.6 Russia Natural Killer (NK) Cell Therapeutics Market Size, 2018-2035
6.4.7 Nordic Countries Natural Killer (NK) Cell Therapeutics Market Size, 2018-2035
6.4.8 Benelux Natural Killer (NK) Cell Therapeutics Market Size, 2018-2035
6.5 Asia
6.5.1 By Region - Asia Natural Killer (NK) Cell Therapeutics Revenue, 2018-2035
6.5.2 China Natural Killer (NK) Cell Therapeutics Market Size, 2018-2035
6.5.3 Japan Natural Killer (NK) Cell Therapeutics Market Size, 2018-2035
6.5.4 South Korea Natural Killer (NK) Cell Therapeutics Market Size, 2018-2035
6.5.5 Southeast Asia Natural Killer (NK) Cell Therapeutics Market Size, 2018-2035
6.5.6 India Natural Killer (NK) Cell Therapeutics Market Size, 2018-2035
6.6 South America
6.6.1 By Country - South America Natural Killer (NK) Cell Therapeutics Revenue, 2018-2035
6.6.2 Brazil Natural Killer (NK) Cell Therapeutics Market Size, 2018-2035
6.6.3 Argentina Natural Killer (NK) Cell Therapeutics Market Size, 2018-2035
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Natural Killer (NK) Cell Therapeutics Revenue, 2018-2035
6.7.2 Turkey Natural Killer (NK) Cell Therapeutics Market Size, 2018-2035
6.7.3 Israel Natural Killer (NK) Cell Therapeutics Market Size, 2018-2035
6.7.4 Saudi Arabia Natural Killer (NK) Cell Therapeutics Market Size, 2018-2035
6.7.5 UAE Natural Killer (NK) Cell Therapeutics Market Size, 2018-2035
7 Natural Killer (NK) Cell Therapeutics Companies Profiles
7.1 Chipscreen Biosciences
7.1.1 Chipscreen Biosciences Company Summary
7.1.2 Chipscreen Biosciences Business Overview
7.1.3 Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Major Product Offerings
7.1.4 Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Revenue in Global Market (2018-2023)
7.1.5 Chipscreen Biosciences Key News & Latest Developments
7.2 Affimed NV
7.2.1 Affimed NV Company Summary
7.2.2 Affimed NV Business Overview
7.2.3 Affimed NV Natural Killer (NK) Cell Therapeutics Major Product Offerings
7.2.4 Affimed NV Natural Killer (NK) Cell Therapeutics Revenue in Global Market (2018-2023)
7.2.5 Affimed NV Key News & Latest Developments
7.3 Altor BioScience
7.3.1 Altor BioScience Company Summary
7.3.2 Altor BioScience Business Overview
7.3.3 Altor BioScience Natural Killer (NK) Cell Therapeutics Major Product Offerings
7.3.4 Altor BioScience Natural Killer (NK) Cell Therapeutics Revenue in Global Market (2018-2023)
7.3.5 Altor BioScience Key News & Latest Developments
7.4 Innate Pharma
7.4.1 Innate Pharma Company Summary
7.4.2 Innate Pharma Business Overview
7.4.3 Innate Pharma Natural Killer (NK) Cell Therapeutics Major Product Offerings
7.4.4 Innate Pharma Natural Killer (NK) Cell Therapeutics Revenue in Global Market (2018-2023)
7.4.5 Innate Pharma Key News & Latest Developments
7.5 Takeda
7.5.1 Takeda Company Summary
7.5.2 Takeda Business Overview
7.5.3 Takeda Natural Killer (NK) Cell Therapeutics Major Product Offerings
7.5.4 Takeda Natural Killer (NK) Cell Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Takeda Key News & Latest Developments
7.6 Sorrento Therapeutics
7.6.1 Sorrento Therapeutics Company Summary
7.6.2 Sorrento Therapeutics Business Overview
7.6.3 Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Major Product Offerings
7.6.4 Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Revenue in Global Market (2018-2023)
7.6.5 Sorrento Therapeutics Key News & Latest Developments
7.7 NantKwest
7.7.1 NantKwest Company Summary
7.7.2 NantKwest Business Overview
7.7.3 NantKwest Natural Killer (NK) Cell Therapeutics Major Product Offerings
7.7.4 NantKwest Natural Killer (NK) Cell Therapeutics Revenue in Global Market (2018-2023)
7.7.5 NantKwest Key News & Latest Developments
7.8 Bristol-Myers Squibb
7.8.1 Bristol-Myers Squibb Company Summary
7.8.2 Bristol-Myers Squibb Business Overview
7.8.3 Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Major Product Offerings
7.8.4 Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Revenue in Global Market (2018-2023)
7.8.5 Bristol-Myers Squibb Key News & Latest Developments
7.9 NKT
7.9.1 NKT Company Summary
7.9.2 NKT Business Overview
7.9.3 NKT Natural Killer (NK) Cell Therapeutics Major Product Offerings
7.9.4 NKT Natural Killer (NK) Cell Therapeutics Revenue in Global Market (2018-2023)
7.9.5 NKT Key News & Latest Developments
7.10 Henry Ford Health Services
7.10.1 Henry Ford Health Services Company Summary
7.10.2 Henry Ford Health Services Business Overview
7.10.3 Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Major Product Offerings
7.10.4 Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Revenue in Global Market (2018-2023)
7.10.5 Henry Ford Health Services Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Natural Killer (NK) Cell Therapeutics Market Opportunities & Trends in Global Market
Table 2. Natural Killer (NK) Cell Therapeutics Market Drivers in Global Market
Table 3. Natural Killer (NK) Cell Therapeutics Market Restraints in Global Market
Table 4. Key Players of Natural Killer (NK) Cell Therapeutics in Global Market
Table 5. Top Natural Killer (NK) Cell Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Natural Killer (NK) Cell Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Natural Killer (NK) Cell Therapeutics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Natural Killer (NK) Cell Therapeutics Product Type
Table 9. List of Global Tier 1 Natural Killer (NK) Cell Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Natural Killer (NK) Cell Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2022 & 2035
Table 12. By Type - Natural Killer (NK) Cell Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Natural Killer (NK) Cell Therapeutics Revenue in Global (US$, Mn), 2024-2035
Table 14. By Application ? Global Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2022 & 2035
Table 15. By Application - Natural Killer (NK) Cell Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Natural Killer (NK) Cell Therapeutics Revenue in Global (US$, Mn), 2024-2035
Table 17. By Region ? Global Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2022 & 2035
Table 18. By Region - Global Natural Killer (NK) Cell Therapeutics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Natural Killer (NK) Cell Therapeutics Revenue (US$, Mn), 2024-2035
Table 20. By Country - North America Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2024-2035
Table 22. By Country - Europe Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2024-2035
Table 24. By Region - Asia Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2024-2035
Table 26. By Country - South America Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2024-2035
Table 28. By Country - Middle East & Africa Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2024-2035
Table 30. Chipscreen Biosciences Company Summary
Table 31. Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Product Offerings
Table 32. Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 33. Chipscreen Biosciences Key News & Latest Developments
Table 34. Affimed NV Company Summary
Table 35. Affimed NV Natural Killer (NK) Cell Therapeutics Product Offerings
Table 36. Affimed NV Natural Killer (NK) Cell Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 37. Affimed NV Key News & Latest Developments
Table 38. Altor BioScience Company Summary
Table 39. Altor BioScience Natural Killer (NK) Cell Therapeutics Product Offerings
Table 40. Altor BioScience Natural Killer (NK) Cell Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 41. Altor BioScience Key News & Latest Developments
Table 42. Innate Pharma Company Summary
Table 43. Innate Pharma Natural Killer (NK) Cell Therapeutics Product Offerings
Table 44. Innate Pharma Natural Killer (NK) Cell Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 45. Innate Pharma Key News & Latest Developments
Table 46. Takeda Company Summary
Table 47. Takeda Natural Killer (NK) Cell Therapeutics Product Offerings
Table 48. Takeda Natural Killer (NK) Cell Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 49. Takeda Key News & Latest Developments
Table 50. Sorrento Therapeutics Company Summary
Table 51. Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Product Offerings
Table 52. Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 53. Sorrento Therapeutics Key News & Latest Developments
Table 54. NantKwest Company Summary
Table 55. NantKwest Natural Killer (NK) Cell Therapeutics Product Offerings
Table 56. NantKwest Natural Killer (NK) Cell Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 57. NantKwest Key News & Latest Developments
Table 58. Bristol-Myers Squibb Company Summary
Table 59. Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Product Offerings
Table 60. Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 61. Bristol-Myers Squibb Key News & Latest Developments
Table 62. NKT Company Summary
Table 63. NKT Natural Killer (NK) Cell Therapeutics Product Offerings
Table 64. NKT Natural Killer (NK) Cell Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 65. NKT Key News & Latest Developments
Table 66. Henry Ford Health Services Company Summary
Table 67. Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Product Offerings
Table 68. Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 69. Henry Ford Health Services Key News & Latest Developments
List of Figures
Figure 1. Natural Killer (NK) Cell Therapeutics Segment by Type in 2022
Figure 2. Natural Killer (NK) Cell Therapeutics Segment by Application in 2022
Figure 3. Global Natural Killer (NK) Cell Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Natural Killer (NK) Cell Therapeutics Market Size: 2022 VS 2035 (US$, Mn)
Figure 6. Global Natural Killer (NK) Cell Therapeutics Revenue, 2018-2035 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Natural Killer (NK) Cell Therapeutics Revenue in 2022
Figure 8. By Type - Global Natural Killer (NK) Cell Therapeutics Revenue Market Share, 2018-2035
Figure 9. By Application - Global Natural Killer (NK) Cell Therapeutics Revenue Market Share, 2018-2035
Figure 10. By Type - Global Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2022 & 2035
Figure 11. By Type - Global Natural Killer (NK) Cell Therapeutics Revenue Market Share, 2018-2035
Figure 12. By Application - Global Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2022 & 2035
Figure 13. By Application - Global Natural Killer (NK) Cell Therapeutics Revenue Market Share, 2018-2035
Figure 14. By Region - Global Natural Killer (NK) Cell Therapeutics Revenue Market Share, 2018-2035
Figure 15. By Country - North America Natural Killer (NK) Cell Therapeutics Revenue Market Share, 2018-2035
Figure 16. US Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 17. Canada Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 18. Mexico Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 19. By Country - Europe Natural Killer (NK) Cell Therapeutics Revenue Market Share, 2018-2035
Figure 20. Germany Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 21. France Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 22. U.K. Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 23. Italy Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 24. Russia Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 25. Nordic Countries Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 26. Benelux Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 27. By Region - Asia Natural Killer (NK) Cell Therapeutics Revenue Market Share, 2018-2035
Figure 28. China Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 29. Japan Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 30. South Korea Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 31. Southeast Asia Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 32. India Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 33. By Country - South America Natural Killer (NK) Cell Therapeutics Revenue Market Share, 2018-2035
Figure 34. Brazil Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 35. Argentina Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 36. By Country - Middle East & Africa Natural Killer (NK) Cell Therapeutics Revenue Market Share, 2018-2035
Figure 37. Turkey Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 38. Israel Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 39. Saudi Arabia Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 40. UAE Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 41. Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Affimed NV Natural Killer (NK) Cell Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Altor BioScience Natural Killer (NK) Cell Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Innate Pharma Natural Killer (NK) Cell Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Takeda Natural Killer (NK) Cell Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. NantKwest Natural Killer (NK) Cell Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. NKT Natural Killer (NK) Cell Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Industry Market Size
